WASHINGTON (Reuters) – U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer’s disease, the company said.
24/7 haber gündem piyasalar son dakika
WASHINGTON (Reuters) – U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer’s disease, the company said.
